Colizzi, Marco
Comacchio, Carla
Garzitto, Marco
Bucciarelli, Lavinia
Candolo, Anna
Cesco, Maddalena
Croccia, Veronica
Ferreghini, Alessandra
Martinelli, Rosita
Nicotra, Alessandra
Sebastianutto, Giulia
Balestrieri, Matteo
Article History
Received: 28 January 2024
Accepted: 27 November 2024
First Online: 4 December 2024
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the Department of Medicine (DMED) at the University of Udine (133/2023). Participants provided their written informed consent to participate in this study.
: Marco Colizzi has been a consultant/advisor to GW Pharma Limited, GW Pharma Italy SRL, and F. Hoffmann-La Roche Limited, outside of this work. The other authors declare no conflict of interest.